BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.411
+0.011 (0.81%)
Nov 21, 2024, 1:31 PM EST - Market open
BioRestorative Therapies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 10 | 8 | 10 | 15 | 1 | 0 | |
Market Cap Growth | 44.11% | -18.94% | -33.36% | 1737.36% | 275.14% | -97.79% | |
Enterprise Value | -3 | -4 | -6 | 20 | 8 | 8 | |
Last Close Price | 1.40 | 1.74 | 2.75 | 4.34 | 27.60 | 20.00 | |
PS Ratio | 25.65 | 56.17 | 84.33 | 329.56 | 10.72 | 1.69 | |
PB Ratio | 0.97 | 0.82 | 0.98 | 0.70 | -0.62 | -0.02 | |
P/TBV Ratio | 1.29 | 0.88 | 1.07 | 0.72 | - | - | |
EV/Sales Ratio | - | - | - | 442.81 | 109.22 | 60.04 | |
Debt / Equity Ratio | 0.00 | 0.02 | 0.03 | 0.03 | -3.60 | -0.61 | |
Asset Turnover | 0.03 | 0.01 | 0.01 | 0.00 | 0.03 | 0.10 | |
Quick Ratio | 2.89 | 4.25 | 2.47 | 57.81 | 2.95 | 0.00 | |
Current Ratio | 2.95 | 4.37 | 2.53 | 59.01 | 3.05 | 0.01 | |
Return on Equity (ROE) | -17.12% | -102.66% | -82.93% | -437.23% | - | - | |
Return on Assets (ROA) | -53.24% | -65.50% | -60.99% | -122.70% | -59.18% | -396.43% | |
Return on Capital (ROIC) | -65.51% | -91.65% | -72.18% | -127.82% | - | - | |
Earnings Yield | -20.16% | -127.21% | -130.88% | -292.25% | -1366.26% | -6659.95% | |
FCF Yield | -78.82% | -80.61% | -61.16% | -22.17% | -238.07% | -3161.94% | |
Buyback Yield / Dilution | -74.41% | -16.60% | -204.60% | -200.92% | - | - | |
Total Shareholder Return | -74.41% | -16.60% | -204.60% | -200.92% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.